ZEB1 and lung adenocarcinoma: Zotarolimus alone and zotarolimus combined with 5-FU reduced the metastatic ability of the A549 lung adenocarcinoma cells, which may be attributed to the decreased mRNA expression of ZEB1 (Figure A6).